Search results
Author(s):
Alejandro de la Sierra
Added:
3 years ago
The Concepts of Metabolic Syndrome and Cardiometabolic Risk
Cardiometabolic risk represents a situation where the possibilities of developing atherosclerotic cardiovascular disease and diabetes are significantly enhanced as a consequence of the presence of insulin resistance and atherogenic dyslipidaemia. Dyslipidaemia is characterised by the presence of low high-density lipoprotein (HDL)…
View more
Author(s):
Nicolas Meneveau
,
Andrew SP Sharp
,
Adriaan Kraaijeveld
Added:
5 years ago
Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, experience and data
Part 1 - Prof Nicolas Meneveau
Part 2 - Prof Andrew Sharp
Part 3 - Dr Adriaan Kraaijeveld
View more
Author(s):
Andrew SP Sharp
,
Adriaan Kraaijeveld
,
Nicolas Meneveau
Added:
5 years ago
Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, experience and data
Satellite symposium at ESC Congress 2018 sponsored by EKOS Corporation
Part 1: Prof Nicolas Meneveau - (Besancon, FR)
Part 2: Prof Andrew Sharp - (Exeter, UK)
Part 3: Prof Adriaan Kraaijeveld - (Utrecht, NL)
View more
TCT 2018: SYNTAXES
Author(s):
Daniel JFM Thuijs
Added:
5 years ago
Video
Author(s):
Nicolas Meneveau
,
Andrew SP Sharp
,
Adriaan Kraaijeveld
Added:
5 years ago
Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, experience and data
Part 1 - Prof Nicolas Meneveau
Part 2 - Prof Andrew Sharp
Part 3 - Dr Adriaan Kraaijeveld
View more
TCT 2018: PORTICO-I
Author(s):
Lars Søndergaard
Added:
5 years ago
Video
TCT 2018: REDUCE-FMR
Author(s):
Horst Sievert
Added:
5 years ago
Video
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
2 years ago
In the latest episode of View from the Thoraxcenter, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their concise analysis of the late-breaking trials that will be presented at AHA Scientific Sessions 2021.
What presentations should we look out for? Get your quick update on the importance of trials such as AVATAR, COSMOS, PARABLE and many more.
View more
Author(s):
Alexander Lauten
Added:
4 years ago
Prof Alexander Lauten (Charité – Universitätsmedizin Berlin, Berlin, DE) diskutiert ergebnisse des TRuE-Registers - Risikostratifizierung bei Patienten mit hochgradiger Trikuspidalinsuffizienz.
Fragen:
1. Können Sie für uns das TRuE-Register zusammenfassen?
2.Wie wurden die Daten gesammelt und analysiert?
3.Was sind die Hauptfeststellungen und welche Schlussfolgerungen können aus dem TRuE…
View more
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
2 years ago
In the latest episode of View from the Thoraxcenter, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their concise analysis of the late-breaking trials that will be presented at TCT 2021.
What presentations should we look out for? Get your quick update on the importance of trials such as FAME 3, RADIANCE-HTN, and PARTNER 3 and many more.
Editor:…
View more